The c-Myc target gene network

Dang, Chi V., O’Donnell, Kathryn A., Zeller, Karen I., Nguyen, Tam, Osthus, Rebecca C., Li, Feng·2006·Seminars in Cancer Biology

Cited by (1,000)

Items 901–1,000 of 1,000

  1. Management of Patients with MYC-Altered Lymphomas
    Daniel Jeffrey Landsburg · 2016 · Current Hematologic Malignancy Reports
  2. Effects of Three Dimensional Microenvironment on Tumorigenicity of Fibrosarcoma in vitro
    Irit Levinger, Racheli Zagouri, Yvonne Ventura, Razi Vago · 2014 · Cancer Studies and Molecular Medicine - Open Journal
  3. Precursor Lesions of Pancreatic Cancer
    Hanno Matthaei, Anirban Maitra · 2010 · Springer eBooks
  4. Contribution à la définition d'un langage générique de modélisation d'entreprise
    Matthieu Roque · 2005 · Oskar-Bordeaux (Universite de Bordeaux)
  5. Luminescence complementation technology for the identification of MYC:TRRAP inhibitors
    Feris, Edmond J., Hinds, John W., Cole, Michael D. · 2021 · Oncotarget
  6. Beyond the Limit: MYC Mediates Tumor Immune Escape
    Zhongyang Hong, Sitong Ming, Xin Luan, Zhe Sun, Weidong Zhang · 2025 · Pharmaceuticals
  7. Regulation of lipid and serine metabolism by the oncogene c-Myc
    Subhajit Chatterjee, Prarthana Prashanth, Vipin Rawat, Sounak Ghosh Roy · 2024 · International review of cytology
  8. Lymphomes de Burkitt
    Vincent Ribrag, Jacques Bosq · 2002 · Encyclopédie médico-chirurgicale. Hématologie
  9. Cellular experiments to study the inhibition of c-Myc/MAX heterodimerization
    Ashutosh Kumar Singh, Shilpa Sharma, Praveen Kumar, Neha Garg · 2022 · Methods in enzymology on CD-ROM/Methods in enzymology
  10. Transcriptomic Analysis of Human Skeletal Muscle in Response to Aerobic Exercise and Protein Intake
    Xueqing Zeng, Linghong Li, Zhilin Xia, Lianhong Zou, Timothy C. Y. Kwok, Yi Su · 2023 · Nutrients
  11. Enhancing breast cancer outcomes with machine learning-driven glutamine metabolic reprogramming signature
    Xukui Li, Xue Li, Bin Yang, Songyang Sun, Shu Wang, Fuxun Yu, Tao Wang · 2024 · Frontiers in Immunology
  12. Increased c-MYC Expression Associated with Active IGH Locus Rearrangement: An Emerging Role for c-MYC in Chronic Lymphocytic Leukemia
    Kenza Guiyedi, Milène Parquet, Saïd Aoufouchi, Jasmine Chauzeix, David Rizzo, Israa Al Jamal, Jean Feuillard, Nathalie Gachard, Sophie Péron · 2024 · Cancers
  13. STK32C promotes colon tumor progression through activating c-MYC signaling
    Xin Zhang, Mingxin Jin, Yali Chu, Fengjun Liu, Hui Qü, Cheng Chen · 2025 · Cellular and Molecular Life Sciences
  14. Altered expression of Bcl-2 , c-Myc , H-Ras , K-Ras , and N-Ras does not influence the course of mycosis fungoides
    Joanna Maj, Alina Jankowska‐Konsur, Ewa Plomer-Niezgoda, Anna Sadakierska−Chudy, Adam Reich · 2013 · Archives of Medical Science
  15. Double-Hit Lymphoma Demonstrating t(6;14;18)(p25;q32;q21), Suggesting Two Independent Dual-Hit Translocations, MYC/BCL-2 and IRF4/BCL-2
    Rie Tabata, Ryoji Yasumizu, Chiharu Tabata, Masaru Kojima · 2013 · Journal of the Japan Society of the Reticuloendothelial System
  16. Molecular Pathogenesis of Prostate Cancer: Somatic, Epigenetic, and Genetic Alterations
    Carlise R. Bethel, Angelo Michael De Marzo, William G. Nelson · 2009 · Elsevier eBooks
  17. Pathobiology of Acute Lymphoblastic Leukemia
    Melissa Burns, Scott A. Armstrong, Alejandro Gutiérrez · 2017 · Elsevier eBooks
  18. Targeting Promoter G-Quadruplexes for Transcriptional Control
    Rhianna K. Morgan, Tracy Ann Brooks · 2018 · Royal Society of Chemistry eBooks
  19. Glutamine stabilizes myc via alpha-ketoglutarate and regulates paclitaxel sensitivity
    Vikas Bhardwaj, Jun He, Aditi Jain · 2022 · Medical Oncology
  20. A Pan-cancer Analysis to Determine the Prognostic Analysis and Immune Infiltration of HSPA5
    Rong-Kun Zhu, Wei Zhang, Yi-Xing Zhang, Zeng hui, Xiongwei Wang · 2023 · Current Cancer Drug Targets
  21. Anoikis-related mRNA-lncRNA and DNA methylation profiles for overall survival prediction in breast cancer patients
    Huili Yang, Wang‐Ren Qiu, Zi Liu · 2024 · Mathematical Biosciences & Engineering
  22. Circular RNA as a Biomarker for Diagnosis, Prognosis and Therapeutic Target in Acute and Chronic Lymphoid Leukemia
    Mohammad Abohassan, Abdulrahman Qais Khaleel, Harikumar Pallathadka, Ashwani Kumar, Omer Qutaiba B. Allela, Ahmed M. Hjazi, Atreyi Pramanik, Yasser Fakri Mustafa, Hamza Fadhel Hamzah, Bahira Abdulrazzaq Mohammed · 2024 · Cell Biochemistry and Biophysics
  23. High mobility group AT‑hook 2 and c‑MYC as potential prognostic factors in pancreatic ductal adenocarcinoma
    Ke Li, Jiali Yang, Jiafei Chen, Yanshu Shi, Zhuoli Zhang, Wei Chen · 2019 · Oncology Letters
  24. Classification of equine lymphoma
    Timothy J. Scase · 2008 · Equine Veterinary Education
  25. The prostate cancer risk locus at 10q11 is associated with DNA repair capacity
    Antje E. Rinckleb, Harald Surowy, Manuel Luedeke, Dominic Varga, Mark G. Schrader, Josef J. Hoegel, Walther Vogel, Christiane Maier · 2012 · DNA repair
  26. Alteraciones del gen c-Myc en la oncogénesis
    Mariano Ospina Pérez, Carlos Mario Muñetón Peña · 2012 · IATREIA
  27. Downregulation of myc Promoter-Binding Protein 1 (MBP-1) in Growth-Arrested Malignant B cells
    Daniel Tvrdík, Pavel Dundr, Ctibor Povýsil, P. Přikryl, S Melcáková, M Planková · 2007 · Folia Biologica
  28. Cancer Gene Pathways
    Fred Bunz · 2016 · Springer eBooks
  29. Chromosomal Translocations in B Cell Lymphomas
    Marco Fangazio, Laura Pasqualucci, Riccardo Dalla‐Favera · 2015 · Springer eBooks
  30. Isotretinoin and Thalidomide Down-Regulate c-MYC Gene Expression and Modify Proteins Associated with Cancer in Hepatic Cells
    Patricia Nefertari Ramírez-Flores, Paulina J. Barraza-Reyna, Alain Aguirre-Vázquez, María Elena Camacho-Moll, Carlos Enrique Guerrero-Beltrán, Diana Reséndez‐Pérez, Vianey González-Villasana, Jesús Norberto Garza-González, Beatriz Silva-Ramírez, Fabiola Castorena‐Torres et al. · 2021 · Molecules
  31. Unveiling the effects of GSK126 on osteosarcoma cells implications for apoptosis, autophagy, and cellular migration
    Xifeng Xiong, Yulin Liu, Yanli Du, Xudong Lai, Chunming Si, Haixiong Miao · 2025 · Discover Oncology
  32. Anthocyanin Derived NIR Fluorogenic Probe for Direct Visualization and Monitoring of DNA G-Quadruplex in Breast Cancer Tumor Models
    Yuan Zhang, Lingyun Zhao, Yuxiang Zheng, Jiaxin Yu, Zili Li, Mengqin Liu, Wen Chen · 2025 · Chemical & Biomedical Imaging
  33. Amino acid metabolic reprogramming: future prospects for cholangiocarcinoma therapy
    Sijia Hua, Fan Fei, Jiawen Li, Yuting Liu, Yuhong Gao, Xiang Wang, Xiulin Dong, Qiang Liu, Jianfeng Yang · 2026 · Cell Death Discovery
  34. Cancer Drug Resistance and Metabolic Reprogramming
    Shariqa Jan, Kaneez Fatima, Abubakar Wani, Fayaz Ahmad Malik, Sameer Ullah Khan · 2024 · Springer eBooks
  35. Biologie moléculaire et cancer de prostate : évolution ou révolution ?
    Vincent Molinié, Philippe Beuzeboc, Wafa Koubâa Mahjoub · 2008 · Annales de Pathologie
  36. Epstein–Barr Virus and Burkitt’s Lymphoma
    Shuvomoy Banerjee, Hem Chandra Jha, Qiliang Cai, Erle S. Robertson · 2012 · Springer eBooks
  37. The mTOR Complexes in Cancer Cell Metabolism
    Thomas P. Lynch, Joseph Gennaro Moloughney, Estela Jacinto · 2016 · Cancer drug discovery and develogment/Cancer drug discovery and development
  38. Metabolic Reprogramming and Cancer
    Ana Paula Lepique, Enrique Boccardo, Flávia Sardela de Miranda · 2021 · Springer eBooks
  39. Lymphome de Burkitt
    Vincent Ribrag, Valérie Camara‐Clayette, Jacques Bosq, Y. Vasstezky · 2012 · Encyclopédie médico-chirurgicale. Hématologie
  40. PHOSPHO1 Serves as a Key Metabolism-Related Biomarker in the Tumorigenesis of Diffuse Large B-cell Lymphoma
    Tianrui Chen, Huang-ming Cao, Yin Wu, Jiang-tao Xie, Haifeng Lan, Lina Jin · 2022 · Current Medical Science
  41. Genetic Analysis of HIBM Myopathy-Specific GNE V727M Hotspot Mutation Identifies a Novel COL6A3 Allied Gene Signature That Is Also Deregulated in Multiple Neuromuscular Diseases and Myopathies
    Shivangi Attri, Moien Rasheed Lone, Amit Katiyar, Vikas Sharma, Vinay Kumar, Chaitenya Verma, Suresh Kumar Gahlawat · 2023 · Genes
  42. A Review of the Molecular Mechanisms of EGFR and IGFR Receptors in Tamoxifen Resistance in Breast Cancer
    Sepideh Mansouri, Tannaz Samadi, Azin Teimurzadeh, Keivan Majidzadeh‐A, Leila Farahmand · 2022 · Multidisciplinary Cancer Investigation
  43. Functional Roles of the lncRNA MALAT1 in Glioma
    Arya Moftakhar, Sajad Najafi, Omid Anbiyaee, Maryam Farzaneh, Seyed Esmaeil Khoshnam · 2023 · Current Cancer Therapy Reviews
  44. Crosstalk between cell fate and survival pathways during uterine cervical carcinoma progression: a molecular and clinical perspective
    Sudip Samadder, Palash Paul, Arpan De · 2023 · Journal of Cancer Metastasis and Treatment
  45. Regulation of the somatotropic axis by MYC-mediated miRNA repression
    Anna P. Petrashen, Andrew D. Verdesca, Jill A. Kreiling, John M. Sedivy · 2023 · Frontiers in Cell and Developmental Biology
  46. GRK4, A Potential Link between Hypertension and Breast Cancer.
    Wei Yue, John J Gildea, Peng Xu, Robin Allen Felder · 2022 · PubMed
  47. Panoramic view of key cross-talks underpinning the oral squamous cell carcinoma stemness - unearthing the future opportunities
    Soujanya J. Vastrad, Giri Ritesh, Sowmya S. V, Ganesan Rajalekshmi Saraswathy, Dominic Augustine, Khalid Jamaan Alzahrani, Fuad M. Alzahrani, Ibrahim F. Halawani, Heba Mahmoud Ashi, Mohammed Alshahrani et al. · 2023 · Frontiers in Oncology
  48. The Eyes Absent family: At the intersection of DNA repair, mitosis, and replication
    Christopher B. Nelson, Jadon Wells, Hilda A. Pickett · 2024 · DNA repair
  49. ARMCX1 inhibits lung adenocarcinoma progression by recruiting FBXW7 for c-Myc degradation
    Zhe Hu, Yilin Wu, Xiaoou Sun, Yanli Tong, Houkuang Qiu, Enqing Zhuo · 2024 · Biology Direct
  50. Delineating MYC-Mediated Escape Mechanisms from Conventional and T Cell-Redirecting Therapeutic Antibodies
    A. Vera de Jonge, Tamás Csikós, Merve Eken, Elianne P. Bulthuis, Pino J. Poddighe, Margaretha G.M. Roemer, Martine E.D. Chamuleau, Tuna Mutis · 2024 · International Journal of Molecular Sciences
  51. Ezrin, a novel marker of ependymal cells, can be used to demonstrate their proliferation regulation after spinal cord injury in mice
    Lin Zhang, Yao-Mei Xu, Ming-Ming Bian, Hua-Zheng Yan, Jian-Xiong Gao, Qian-Hui Bao, Yuqing Chen, Shu‐Qin Ding, Rui Wang, Nan Zhang et al. · 2024 · Neurobiology of Disease
  52. The MYCN Oncogene
    Leanna Cheung, E. Jayne, Michelle Haber, Murray D. · 2013 · InTech eBooks
  53. Molecular pathways leading to cancer as a basis for preventive strategies
    Mark A. Hull · 2008 · Current Colorectal Cancer Reports
  54. Driving gradual endogenous c-myc overexpression by flow-sorting: intracellular signaling and tumor cell phenotype correlate with oncogene expression
    Kasper Jermiin Knudsen, Gitte‐Mai Nelander Holm, Jonas S. Krabbe, Nicolai Listov‐Saabye, Bénédicte Kiehr, Martin Dufva, Jette E. Svendsen, Martin B. Oleksiewicz · 2009 · Archives of Toxicology
  55. Selective Activation of Alternative MYC Core Promoters by Wnt-Responsive Enhancers
    Jorge A. Bardales, Evin Wieser, Hideya Kawaji, Yasuhiro Murakawa, Xavier Darzacq · 2018 · Genes
  56. Image‐Based Analysis of Protein Stability
    K. Ashley Hickman, Santosh Hariharan, Jason De Melo, Jarkko Ylanko, Lindsay C. Lustig, Linda Z. Penn, David William Andrews · 2019 · Cytometry Part A
  57. Childhood Lymphoma
    John T. Sandlund, Mihaela M. Onciu · 2014 · Elsevier eBooks
  58. The Effect of Acute and Chronic Infection-Induced by AvrA Protein of Salmonella typhimurium on Radical Oxygen Species, Phosphatase and Tensin Homolog, and Cellular Homolog Expression During the Development of Colon Cancer
    Satuman Satuman, Desi Sandra Sari, Eva Rachmi, Eddy Herman Tanggo, Hari Basuki Notobroto, Ketut Sudiana, Sofia Mubarika, Fedik Abdul Rantam, Soemarno Soemarno, Eddy Bagus Wasito · 2021 · Open Access Macedonian Journal of Medical Sciences
  59. G‐Quadruplex DNA and its Ligands in Anticancer Therapy
    Zhi‐Shu Huang, Jia‐Heng Tan, Tian‐Miao Ou, Ding Li, Lian‐Quan Gu · 2011
  60. Differential expression between African-ancestry and White patients diagnosed with Triple-Negative Breast Cancer: EGFR, Myc, Bcl2 and β-Catenin as ancestry-associated markers
    Ana T. Matias, Ana Jacinta-Fernandes, Ana-Teresa Maia, Sofia Braga, António Jacinto, Maria Guadalupe Cabral, Patrícia H. Brito · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  61. Correction: Combined Analysis of Murine and Human Microarrays and ChIP Analysis Reveals Genes Associated with the Ability of MYC To Maintain Tumorigenesis
    Chi-hwa Wu, Debashis Sahoo, Constadina Arvanitis, Nicole Bradon, David L. Dill, Dean W. Felsher · 2013 · PLoS Genetics
  62. Comprehensive Proteomics and Machine Learning Analysis to Distinguish Follicular Adenoma and Follicular Thyroid Carcinoma from Indeterminate Thyroid Nodules
    Hee‐Sung Ahn, Eyun Song, Chae A Kim, Min Ji Jeon, Yu‐Mi Lee, Tea-Yon Sung, Dong Eun Song, Jiyoung Yu, Ji Hoon Shin, Yeon‐Sook Choi et al. · 2025 · Endocrinology and Metabolism
  63. A Glycerophospholipid Metabolism-Based Prognostic Model Guides Osteosarcoma Therapy
    Yong Wen, Donglian Wang, Hongshen Wang, Jian Zhao, Yao Li, Jin Zhang, Bolai Chen · 2025 · Translational Oncology
  64. Triglyceride lipase PNPLA2–independent suppression of c-MYC signaling by the metabolic coactivator ABHD5 in prostate cancer
    Aaron Lotvola, Guohua Chen, Guoli Zhou, James G. Granneman, Jian Wang · 2025 · Journal of Biological Chemistry
  65. c-Myc: Central regulator of autophagy and senescence in cancer
    Shuai Ji, Ting Sun, Qi Zhang, Mingyue Wu, Yang Cao, Ran Gao, Lingzhi Wang, Christophe Nicot, Gautam Sethi · 2026 · Cancer Letters
  66. Whole blood transcriptional signatures of age and survival identified in long life family and integrative longevity omics studies
    Mengze Li, Zeyuan Song, Eric R. Reed, Tanya T. Karagiannis, Stacy L. Andersen, Michael R. Brent, Chase Mateusiak, Sandeep Acharya, Wooseok J. Jung, Shu Liao et al. · 2026 · GeroScience
  67. Can We Exploit the Molecular Heterogeneity of Aggressive B Cell Lymphomas Into Effective New Therapies?
    Daniel Jeffrey Landsburg, Brad S. Kahl · 2018 · Clinical Lymphoma Myeloma & Leukemia
  68. High-grade B-cell Non-Hodgkin’s Lymphoma Masquerading as Thyroid Carcinoma; a Case Report
    Ali Murad Jamal, Rizwan Bilal, Imran Khalid Niazi, Humayun Bashir · 2020 · Journal of Cancer & Allied Specialties
  69. Childhood Lymphoma
    John T. Sandlund, Mihaela M. Onciu · 2020 · Elsevier eBooks
  70. A dynamic fluorescence probed glycolysis suppression process in HeLa cells treated with trichostatin A
    Fengqiu Zhang, Changsheng Shao, Yahui Wu, Wei Zhao, Xumiao Jing, Cao Fang, Qing Huang · 2022 · The Analyst
  71. Diagnostic and prognostic value of c-MYC gene expression in hematological malignancies
    Ifeyinwa Maryann Okafor, Henshaw Uchechi Okoroiwu, Christopher Ogar Ogar · 2023 · African Health Sciences
  72. Clinicopathologic Characteristics of MYC Copy Number Amplification in Breast Cancer
    Tong Sun, Reza Golestani, Haiying Zhan, Uma Krishnamurti, Malini Harigopal, Minghao Zhong, Yuanxin Liang · 2024 · International Journal of Surgical Pathology
  73. SLC15A2 Serves as a Novel Prognostic Biomarker and Target for Prostate Cancer
    WENJUN YIN, Ping He, Zhihao Zou, Jundong Lin, Zhenguo Liang, Zhenjie Wu, Jianheng Ye, Jianming Lü, Weide Zhong · 2024 · Anticancer Research
  74. In Silico Identification of LSD1 Inhibition-Responsive Targets in Small Cell Lung Cancer
    İhsan Nalkıran, Hatice Sevim Nalkıran, Neslihan Özçelik, Mehmet Kıvrak · 2025 · Bioengineering
  75. Physiological Expression and Accumulation of the Products of Two Upstream Open Reading Frames mrtl and MycHex1 Along With p64 and p67 Myc From the Human c‐myc Locus
    Mi Hong Ji, Seung‐Ki Kim, Chae‐Yong Kim, Ji Hoon Phi, Hyun Jin Jun, Scott W. Blume, Hyoung Soo Choi · 2015 · Journal of Cellular Biochemistry
  76. Characterization of two new high-grade B-cell lymphoma cell lines withMYCandBCL2rearrangements that are suitable forin vitrodrug sensitivity studies
    Marie-Sophie Dheur, Hélène Antoine Poirel, Geneviève Ameye, Gaëlle Tilman, Pascale Saussoy, Jean‐Philippe Defour, Alessandra Camboni, Éric Van Den Neste, Pierre G. Coulie, Nicolas van Baren · 2018 · Leukemia & lymphoma/Leukemia and lymphoma
  77. The Nucleolar Aspect of Breast Cancer
    Judy Yan, Damu Tang · 2013 · Springer eBooks
  78. Identification of recognition sites for Myc/Max/Mxd network proteins by a whole human chromosome 19 selection strategy
    С. Б. Акопов, И. П. Чернов, Therese Wahlström, М. Б. Костина, George Klein, Marie Arsenian‐Henriksson, Л. Г. Николаев · 2008 · Biochemistry (Moscow)
  79. Effect of Celergen, a marine derivative, on in vitro hepatocarcinogenesis
    Roberto Catanzaro · 2013 · Drug Discoveries & Therapeutics
  80. FISH in Burkitt lymphoma diagnosis: a single Romanian center experience
    Neicu Ariana, Maria Neagu, Maria Dobre, Raluca Ivan, Camelia Marioara Dobrea · 2013 · Revista română de medicină de laborator
  81. "Double hit" lymphoma or secondary MYC translocation lymphoma?
    Petra Korać, Snježana Dotlić, Mara Dominis · 2012 · Hrčak Portal of scientific journals of Croatia (University Computing Centre)
  82. ◾ Sourcing and Manipulating Stem Cells for Elastin Regeneration Applications
    ANAND RAMAMURTHI BRIAN M. BALOG · 2018 · CRC Press eBooks
  83. Adenovirus E1A TRRAP-targeting domain-mediated enhancement of MYC association with the NuA4 complex activates a panel of MYC target genes enriched for gene expression and ribosome biogenesis
    Ling‐Jun Zhao, Paul M. Loewenstein, Maurice Green · 2017 · Virology
  84. A rare case of near-haploid acute lymphoblastic leukemia
    William Gonzalez-Marques, Ann‐Leslie Zaslav, Dhana Balakrishnan, Laura E. Hogan, Yupo Ma, Daniel Tully, Paula Fernicola, Roxana Ponce, Htien Lee, Theresa Mercado et al. · 2019 · Leukemia Research Reports
  85. MYC copy number and mRNA expression in chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chornobyl NPP accident
    Nadia I. Bilous, Iryna V. Abramenko, Chumak Aa, Iryna Dyagil, Z. Martina · 2020 · Experimental Oncology
  86. Cancer Gene Pathways
    2007 · Springer eBooks
  87. S146L in MYC is a context-dependent activating substitution in cancer development
    John W. Hinds, Edmond J. Feris, Owen Michael Wilkins, Luke T. Deary, Xiaofeng Wang, Michael D. Cole · 2022 · PLoS ONE
  88. Comprehensive Genomic Analysis for Identifying FZD6 as a Novel Diagnostic Biomarker for Acute Myeloid Leukemia
    Li Yang, De-Yu Ma, Shi Tang, Tingting Jiang, Jie Yu, Li Wang, Lin Zou · 2022 · Computational and Mathematical Methods in Medicine
  89. AA28–67 domain within MyD88 suppresses c-myc activity and expression to regulate differentiation and function of dendritic cells
    Zhuohan Zhang, Bin Zeng, Guohui Jiao, Yuhao Li, Yu Liu, Yuan Zhang, Rongcun Yang · 2009 · Clinical Immunology
  90. Molecular Pathogenesis of B Cell Lymphomas
    Riccardo Dalla‐Favera, Laura Pasqualucci · 2014 · Elsevier eBooks
  91. A Glance at Current and Upcoming Applications
    2012 · Wiley eBooks
  92. c-Myc inhibition is critical for HSC expansion and Rad51 expression
    Merve Aksöz, Esra Albayrak, Galip Servet Aslan, Raife Dilek Turan, Lamia Yazgi Alyazici, Pınar Si̇yah, Emre Can Tüysüz, Serli Canikyan, Doğacan Yücel, Neslihan Meriç et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  93. RIOK2 drives glioblastoma cell proliferation by modulating MYC through the RNA-binding protein IMP3
    Alexander S. Chen, Jhomar Marquez, Nathaniel Boyd, Se-Yeong Oh, Riley Gulbronson, Jamie A.G. Hamilton, Emily R. Legan, Renee D Read · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Phytochemicals targeting metabolic reprogramming in cancer: an assessment of role, mechanisms, pathways and therapeutic relevance
    Asifa Khan, Shumaila Iqbal Siddiqui, Syed Akhtar Husain, Sybille Mazurek, Mohammad Askandar Iqbal · 2020
  95. Premature Aging and Reduced Cancer Incidence Associated with Near-Complete Body-Wide Myc Inactivation
    Huabo Wang, Jie Li Lu, Taylor Stevens, Alexander Roberts, Jordan A. Mandel, Raghunandan Avula, Bingwei Ma, Yijen Lin Wu, Jinglin Wang, Clinton Van’t Land et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Rapid, high-resolution, non-destructive assessments of metabolic and morphological homogeneity uniquely identify high-grade cervical precancerous lesions
    Christopher M. Polleys, Pramesh Singh, Hong-Thao Thieu, Elizabeth M. Genega, Narges Jahanseir, Andrea L. Zuckerman, Francisca Rius Díaz, Abani Patra, Afshin Beheshti, Irene Georgakoudi · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Development of Split-Protein Systems: From Binary to Ternary System
    Shengyi Shen · 2021 · Advances in Bioscience and Biotechnology
  98. Altered hormone expression induced genetic changes leads to breast cancer
    Anchal Thakur, Navya Rana, Ranjit Kumar · 2024 · Current Opinion in Oncology
  99. Analysis of Single-Cell RNA-Seq Data to Investigate Tumor Cell Heterogeneity in Uroepithelial Bladder Cancer and Predict Immunotherapy Response
    Lu Zhang, Yu Wang, Jianjun Tan · 2025 · Current Cancer Drug Targets
  100. Physciosporin targeting of cellular myelocytomatosis oncogene in gastric cancer suppresses energy metabolism and metastasis via lysosomal degradation
    Sultan Pulat, Moongi Ji, Songjin Oh, Byeongchan Choi, Mücahit Varlı, So‐Yeon Park, Rui Zhou, Chathurika D. B. Gamage, Jae–Seoun Hur, Man‐Jeong Paik et al. · 2025 · Phytomedicine